Navigation Links
Drug Approved to Curb Alcohol Dependency

A study of alcoholics has revealed that of the two drugs approved for curbing alcoholics' cravings, naltrexone, proved to be little more beneficial than specialized counseling. // However the second drug, acamprosate, on the market was not better than a placebo.

Naltrexone, was sold generically in daily pill form under the brand name,ReVia by Barr Pharmaceuticals Inc., while acamprosate was, marketed under the brand name Campral by Forest Laboratories Inc.

According to lead author of the research, Dr. Raymond Anton, of the Medical University of South Carolina in Charleston who said ‘We were surprised by two findings from our study. One was that acamprosate was no more effective than placebo alone and two, that while naltrexone was effective in its own right, combining it with the specialized counseling added no more effectiveness than naltrexone by itself.’

In effect people could either choose to take naltrexone or to see a specialized counselor who could counsel them about the prevention of a relapse, and dealing with their alcohol addiction.

Naltrexone acts on opiate receptors while acamprosate has its effect on a neurotransmitter. They both have been approved by Food and Drug Administration approval. Naltrexone, made by Alkermes Inc. as an injectable form, to be taken monthly, will be marketed by Cephalon Inc.

The results of the study have been published in the Journal of the American Medical Association.

According to their estimates there are 8 million alcoholics in the United States.

1,400 alcohol-dependent patients who wanted to stop drinking were the participants of the study. They were divided into groups and treated for 16 weeks.

Some of the participants received drugs, while some received a placebo, and some no pills at all. Besides this most subjects were also medically managed by encouraging them to abstain from alcohol and consistently take their medicatio
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New FDA Approved Drug NATRECOR For Heart Failure Patients
4. New Oral Rinse For Gingivitis Approved By FDA
5. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
6. AIDS Generic Drugs Approved by FDA for Sale in US
7. FDA Approved Nerve-Stimulation Therapy Now Available In New York
8. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
9. Pfizer’s Eraxis Approved By The FD
10. Inhalers for Kids Was Approved By the FDA
11. Alcoholism Drug Vivitrol Approved By FDA
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Approved Curb Alcohol Dependency

(Date:3/4/2015)... 04, 2015 Parkview Regional Hospital ... Alan Daugherty has been named chief executive officer ... served as interim CEO of Parkview Regional and ... provided tremendous leadership during his tenure as interim ... strategy and developing relationships with physicians, patients and ...
(Date:3/4/2015)... Nurses, healthcare professionals and the general public ... to learn about why cannabis is a safe and ... conditions. The one-day continuing education (CE) seminar, “ACNA Core ... 1 or April 2 at Aloft Cleveland Downtown. ... Nurses Association (OBN-001-91), an accredited approver by the American ...
(Date:3/3/2015)... Washington, DC (PRWEB) March 04, 2015 ... business into value-based payment contracts within the next few ... — and the significant chunk of health care spending ... Information Services, Inc.’s ACO Business News (ABN) tracks ... the context of a commercial accountable care organization (ACO)-type ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
(Date:3/3/2015)... 03, 2015 Risperdal lawsuits ( ... the atypical antipsychotic medication continue to move forward ... documents, the South Carolina Supreme Court upheld a ... Johnson’s Janssen Pharmaceuticals unit had deceptively marketed the ... the Court’s February 25th decision characterized the company’s ...
Breaking Medicine News(10 mins):Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 2Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 3Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... and laparoscopic surgery found few differences in outcome , ... for men with prostate cancer whether they have open ... , Currently, open radical prostatectomy (ORP) is considered the ... (LRP), with or without robotic assistance, is becoming more ...
... ... ... ... ...
... ... technology products to the Japan market. OEM partners of the RDX storage technology include industry ... , ... -- The RDX® Storage Alliance today announced that Maxell , a technology ...
... ... by 60 Percent , ... Atlanta, GA (PRWEB) February 22, 2010 -- CustomerCentric Selling® (CCS), a proven methodology ... mailing industry leader for over 30 years in providing products and services for all ...
... ... sponsored by Horst Construction, senior living executives will learn about profitable new strategies, especially in ... communities. , ... 22, 2010 -- The 9th Annual Senior Living Conference sponsored by Horst Construction will be ...
... ATLANTA--A new study has found that many male cancer ... radiation therapy have an impaired quality of life and ... , a peer-reviewed journal of the American Cancer Society, ... testosterone deficiency may benefit from testosterone replacement therapy. ...
Cached Medicine News:Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 2Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 3Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 4Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 5Health News:WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility 6Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 2Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 3Health News:CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results 2Health News:CustomerCentric Selling Helps BCC Software Dramatically Boost Sales Performance and Produce Record Results 3Health News:Register Online for this Year's Horst Senior Living Conference on April 8 Featuring Keynote Speaker and Senior Housing Expert Jim Moore 2
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) ... Market in the US 2015-2019" report to their ... the US to grow at a CAGR of 6.11% ... form of high-visibility packaging that uses pre-formed plastic packs ... a base layer, made either of plastic or aluminum, ...
(Date:3/3/2015)... --  Surefire Medical, Inc. today announced the ... Infusion System with an end hole microcatheter.  In ... using the Surefire resulted in statistically significant increases ... significantly decreased uptake in normal liver tissue. The ... of Interventional Radiology (SIR) meeting in ...
(Date:3/3/2015)... PARIS , March 3, 2015 ... enrolled 356 and 240 patients respectively Publications ... Journal of Clinical Gastroenterology highlight diagnostic value ... in China and across ... Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, ...
Breaking Medicine Technology:United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
... of Wolters Kluwer Health and ... for the medical, scientific, and academic markets, is pleased to announce ... the first clinical tool from Ovid designed especially for physicians ... on relevant full-text content from Ovid. It,s the only solution that ...
Cached Medicine Technology:Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 2Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 3Ovid Announces its First Clinical Tool, OvidMD, Designed for Physicians and Other Clinicians 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: